Lipodystrophy syndrome in human immunodeficiency virus-infected children.
about
Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected childrenGetting to 90-90-90 in paediatric HIV: What is needed?Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children.Longitudinal changes in regional fat content in HIV-infected children and adolescents.LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern IndiaAnti-infective use in children and pregnancy: current deficiencies and future challenges.Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapyVirtual support for paediatric HIV treatment decision makingHyperlipidemia in children with HIV infection: an emerging problem.A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection.Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenLipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American childrenShort communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women.The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults.Pediatric HIV infection: the state of antiretroviral therapy.Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.The global burden of oral diseases in pediatric HIV-infected populations: a workshop report.Cardiometabolic disease in human immunodeficiency virus-infected children.PENTA guidelines for the use of antiretroviral therapy, 2004.Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.Effects of highly active antiretroviral therapy on paediatric metabolite levels.Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.Assessment of obesity status in outpatients from three disease states
P2860
Q28483967-F671A9FA-70B9-4A3F-A92D-ADBBB5129732Q30385352-9DAEBE86-4725-48C9-BBB1-51336087D4DAQ33378805-96322D9C-262B-46F9-A373-9111CC885D53Q33693051-65CD0F49-C6F6-493D-9EE9-102B016B81CAQ34058478-03982FC6-D24B-4283-84A2-96E3628F6235Q34335535-7E8739CE-867D-4C25-9363-B846119B5B38Q35023696-B0FFE357-3B31-44A1-A1BE-CA2E668F4C7EQ35205900-DA69E446-C677-4C1E-9A75-9C62D20ECCBBQ35677644-2059EADC-1F3D-4CE0-A458-962DDA2C6704Q35696547-7A7FA8BB-0B68-48BC-A3A4-EA149678F152Q36004865-25E468CA-773A-498B-80A4-7B098C56AA88Q36206201-CD4EE9CE-A419-456E-846A-7A39E9DD0C47Q36349683-32B1A273-ED6F-4CFE-B419-B98B3B8DEBB2Q36386822-DC6A2661-5BCC-4922-B6DA-D28BEB022273Q36542643-8DABFE19-4E0F-49AF-92ED-367E030CBD45Q36961612-5DC361F9-DC2F-4ACE-8E0A-884220B27AE2Q37111446-405AD732-62C7-4804-B0F6-2BD262DFEA11Q37112531-A1EDDB3B-5CAE-48AC-8828-54F4BBBFFBB8Q37124873-075F7B74-257B-4CE9-9346-B1CDAE0886BDQ37187093-80A89480-796C-46D0-81CC-F7B3252819FDQ37435125-7844C141-DD59-4D25-BB6B-874CD797E6BCQ38907470-5F72657C-A1F8-46B1-93DF-216D93764017Q40096020-94F46871-5E5F-44AE-BA5B-3EE3108988AFQ44263320-B42A8B30-B364-4C92-8590-D5599DF2C2E3Q44551426-3F77410E-5E6F-4E03-9D90-A9E034EC17C7Q46824216-A6C6F252-59B6-4967-B37A-5F83AC74D2CBQ47602387-C04E5B98-7096-4B55-B11C-5FF03ED56951Q58899081-4694D8A7-C4E5-443C-B32F-FE500C340C1C
P2860
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@en
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@nl
type
label
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@en
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@nl
prefLabel
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@en
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@nl
P2093
P1476
Lipodystrophy syndrome in human immunodeficiency virus-infected children.
@en
P2093
Ann McMeans
Claudia A Kozinetz
Heidi Schwarzwald
Mark W Kline
Rene A Amaya
P304
P356
10.1097/00006454-200205000-00011
P577
2002-05-01T00:00:00Z